Cytosorbents Corporation (CTSO) vs Optimi Health Corp. (OPTH)
A side-by-side comparison of Cytosorbents Corporation and Optimi Health Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTSO
Cytosorbents Corporation
$4.07HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
OPTH
Optimi Health Corp.
$4.20HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — CTSO vs OPTH
growth of $100 · dividends reinvested · last 6yCTSO -97.6% (-46.3%/yr)OPTH -74.5% (-20.4%/yr)OPTH compounded faster over this window
Log scale — wide-divergence pair
CTSO OPTH
CTSO vs OPTH: by the numbers
- •OPTH is the larger company ($14M vs $13M market cap).
- •Both run net losses; CTSO's is the smaller (-48.94% vs -3972.87% net margin).
Metrics side by side
Valuation
| Metric | CTSO | OPTH |
|---|---|---|
| P/S ratio | 0.34 | 108.72 |
| P/B ratio | N/A | 1.09 |
Profitability
| Metric | CTSO | OPTH |
|---|---|---|
| Gross margin | 71.61% | -486.44% |
| Operating margin | -33.37% | -1062.29% |
| Net margin | -48.94% | -3972.87% |
| ROE | N/A | -39.76% |
| ROIC | -43.31% | -28.72% |
Growth (annualized)
| Metric | CTSO | OPTH |
|---|---|---|
| Revenue CAGR (5Y) | -3.17% | N/A |
| Total return CAGR (5Y) | -52.26% | -21.80% |
Frequently asked
- How have CTSO and OPTH total returns compared?
- Over the past 5 years, CTSO delivered -52.26% and OPTH delivered -21.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.